secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0000950170-25-004646
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker sees Q4 2024 revenue of $970M-$980M; 2025 outlook of upper mid-single digit growth
--------------------------------------------------------------------------------

- Preliminary Q4 2024 revenue guidance of $970M to $980M (unaudited, subject to change).
- BSI segment bookings described as solid in the fourth quarter.
- 2025 constant exchange rate revenue growth outlook: upper mid-single digits, assuming low-single digit market growth.
- Company presented at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.
- Final Q4 and full-year 2024 financial statements have not yet been completed or audited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000095017025004646/0000950170-25-004646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000095017025004646/brkr-20250113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-004646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer